Nanjing Hicin Pharmaceutical Co.,Ltd.’s Net Profit Rose 11.9% in First Half of 2023

Nanjing Hicin Pharmaceutical Co.,Ltd. (南京海辰药业股份有限公司) (300584.SZ) reported a net profit of 19.5 million yuan in the first half of 2023, up 11.9% year-on-year.

Meanwhile, the company posted 261.5 million yuan in revenue, down 2.3% year-on-year.

At the end of the reporting period, it had 1.3 billion yuan in total assets and 350.9 million yuan in total liabilities, with a liability-to-asset ratio of 26.6%.